Department of Medicine, Loma Linda University Medical Center, Loma Linda, California, USA.
Department of Transplant Surgery, Loma Linda University Health, Loma Linda, California, USA.
Am J Transplant. 2022 Oct;22(10):2464-2466. doi: 10.1111/ajt.17067. Epub 2022 May 5.
Coexisting coronary artery disease (CAD), end-stage liver disease (ESLD), renal failure, and hypercoagulable state poses a formidable clinical challenge. Here, we discuss the first known case of a patient with antiphospholipid syndrome (APLS), ESLD complicated by hepatorenal syndrome (HRS), and severe CAD who successfully underwent combined coronary artery bypass grafting (CABG) and simultaneous liver/kidney (SLK) transplant.
并存的冠状动脉疾病(CAD)、终末期肝病(ESLD)、肾衰竭和高凝状态带来了严峻的临床挑战。在这里,我们讨论了首例已知的抗磷脂综合征(APLS)、ESLD 合并肝肾综合征(HRS)和严重 CAD 患者的病例,该患者成功接受了冠状动脉旁路移植术(CABG)和同期肝/肾(SLK)移植。